Swiss National Bank Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Swiss National Bank increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 212,800 shares of the biotechnology company’s stock after buying an additional 500 shares during the quarter. Swiss National Bank owned about 0.28% of Axon Enterprise worth $85,035,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. PFG Investments LLC grew its holdings in shares of Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after buying an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC raised its position in shares of Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares during the period. Mather Group LLC. raised its position in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares during the period. CWM LLC raised its position in shares of Axon Enterprise by 1.3% in the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after acquiring an additional 36 shares during the period. Finally, SPC Financial Inc. raised its position in shares of Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock worth $708,000 after acquiring an additional 38 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Jeri Williams sold 110 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the transaction, the director now directly owns 1,934 shares of the company’s stock, valued at $773,600. This trade represents a 5.38 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. This trade represents a 2.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 411,006 shares of company stock worth $161,360,618. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $600.00 on Tuesday. The firm has a market cap of $45.75 billion, a PE ratio of 155.04, a price-to-earnings-growth ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a 52-week low of $224.16 and a 52-week high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $443.50 and its two-hundred day moving average is $359.89.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.